Merck Kgaa (MKGAF) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck Kgaa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.678 Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference call 00:00:04.678 -- 00:00:07.762 on first quarter 2026. As 00:00:07.762 -- 00:00:11.708 a reminder, all participants will be in a listen-only mode. 00:00:11.708 -- 00:00:15.753 I'm now handing over to Florian Schroeder, Head of Investor Relations, who will lead 00:00:15.753 -- 00:00:19.779 you through this conference. Please go ahead, sir. 00:00:19.779 -- 00:00:25.047 Thank you, Sarah. Highly appreciate everyone joining us for our Q1 26 earnings 00:00:25.047 -- 00:00:30.355 call. My name is Florian Schroeder, and I'm the Head of Investor Relations at Merck. 00:00:30.355 -- 00:00:35.883 I am delighted to be joined by Kai Beckmann, our Group CEO, and Helene von Roeder, Group 00:00:35.883 -- 00:00:40.910 CFO. Kai and Helene will walk us through the key slides and financial highlights of 00:00:40.910 -- 00:00:46.177 the past quarter. And Kai will also take the opportunity to provide an update 00:00:46.177 -- 00:00:49.301 on the company's strategic direction. 00:00:49.301 -- 00:00:54.068 For the Q&A part of the call, we will be further joined by Jean-Charles Dirth, CEO of 00:00:54.068 -- 00:00:59.097 LifeScience, Danny Basohar, CEO of Healthcare, and Benjamin 00:00:59.097 -- 00:01:01.941 Hein, CEO of Electronics. 00:01:01.941 -- 00:01:07.066 And with that long intro, I will turn it over to Kai to get us started. 00:01:07.590 -- 00:01:12.477 Thanks, Florian, for the introduction and welcome everybody to our Q1 earnings call. 00:01:12.477 -- 00:01:17.525 Let us move to slide five. So what to characterize this quarter, I would call 00:01:17.525 -- 00:01:22.893 it a solid start to 2026 despite global challenges. 00:01:22.893 -- 00:01:27.968 Organically, group s...